Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Bionano Genomics Inc (NASDAQ: BNGO) was $0.75 for the day, down -4.73% from the previous closing price of $0.79. In other words, the price has decreased by -$4.73 from its previous closing price. On the day, 0.98 million shares were traded. BNGO stock price reached its highest trading level at $0.81 during the session, while it also had its lowest trading level at $0.75.
Ratios:
Our analysis of BNGO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on January 05, 2023, initiated with a Sector Outperform rating and assigned the stock a target price of $4.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 13 ’23 when Mamuszka Hannah bought 65,789 shares for $0.76 per share. The transaction valued at 50,000 led to the insider holds 65,789 shares of the business.
Holmlin R. Erik bought 15,000 shares of BNGO for $9,639 on May 16 ’23. The President and CEO now owns 806,474 shares after completing the transaction at $0.64 per share. On May 12 ’23, another insider, Stewart Christopher P., who serves as the Chief Financial Officer of the company, bought 50,000 shares for $0.67 each. As a result, the insider paid 33,415 and bolstered with 281,373 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BNGO now has a Market Capitalization of 45923024 and an Enterprise Value of 53662500. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.27 while its Price-to-Book (P/B) ratio in mrq is 0.36. Its current Enterprise Value per Revenue stands at 1.486 whereas that against EBITDA is -0.427.
Stock Price History:
Over the past 52 weeks, BNGO has reached a high of $8.20, while it has fallen to a 52-week low of $0.71. The 50-Day Moving Average of the stock is -31.73%, while the 200-Day Moving Average is calculated to be -67.94%.
Shares Statistics:
BNGO traded an average of 1.61M shares per day over the past three months and 1643530 shares per day over the past ten days. A total of 61.23M shares are outstanding, with a floating share count of 60.58M. Insiders hold about 1.07% of the company’s shares, while institutions hold 10.13% stake in the company. Shares short for BNGO as of 1711584000 were 5270443 with a Short Ratio of 3.26, compared to 1709164800 on 5228669. Therefore, it implies a Short% of Shares Outstanding of 5270443 and a Short% of Float of 9.67.
Earnings Estimates
The dynamic stock of Bionano Genomics Inc (BNGO) is currently attracting attention from Bionano Genomics, Inc. analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.34, with high estimates of $28.58 and low estimates of $6.26.
